Literature DB >> 26250147

Development and validation of the Dimensional Anhedonia Rating Scale (DARS) in a community sample and individuals with major depression.

Sakina J Rizvi1, Lena C Quilty2, Beth A Sproule3, Anna Cyriac4, R Michael Bagby5, Sidney H Kennedy6.   

Abstract

Anhedonia, a core symptom of Major Depressive Disorder (MDD), is predictive of antidepressant non-response. In contrast to the definition of anhedonia as a "loss of pleasure", neuropsychological studies provide evidence for multiple facets of hedonic function. The aim of the current study was to develop and validate the Dimensional Anhedonia Rating Scale (DARS), a dynamic scale that measures desire, motivation, effort and consummatory pleasure across hedonic domains. Following item selection procedures and reliability testing using data from community participants (N=229) (Study 1), the 17-item scale was validated in an online study with community participants (N=150) (Study 2). The DARS was also validated in unipolar or bipolar depressed patients (n=52) and controls (n=50) (Study 3). Principal components analysis of the 17-item DARS revealed a 4-component structure mapping onto the domains of anhedonia: hobbies, food/drink, social activities, and sensory experience. Reliability of the DARS subscales was high across studies (Cronbach's α=0.75-0.92). The DARS also demonstrated good convergent and divergent validity. Hierarchical regression analysis revealed the DARS showed additional utility over the Snaith-Hamilton Pleasure Scale (SHAPS) in predicting reward function and distinguishing MDD subgroups. These studies provide support for the reliability and validity of the DARS.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Anhedonia; Dimensional Anhedonia Rating Scale; Major depressive disorder; Reliability; Scale development; Snaith–Hamilton Pleasure Scale; Validity

Mesh:

Year:  2015        PMID: 26250147     DOI: 10.1016/j.psychres.2015.07.062

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  39 in total

1.  Psychometric properties the of Brazilian Portuguese version of Snaith-Hamilton Pleasure Scale (SHAPS).

Authors:  Ana Paula Jesus-Nunes; João Paulo Barreto Borges Coroa; Felipe Coelho Argolo; Tayne de Miranda Moreira; Mychelle Morais-de-Jesus; Roberta Ferrari Marback; Fernanda S Correia-Melo; Acioly L T Lacerda; Lucas C Quarantini
Journal:  Trends Psychiatry Psychother       Date:  2021-01-22

2.  Unpacking Major Depressive Disorder: From Classification to Treatment Selection.

Authors:  Sidney H Kennedy; Amanda K Ceniti
Journal:  Can J Psychiatry       Date:  2017-12-26       Impact factor: 4.356

3.  Clinical, behavioral, and neural measures of reward processing correlate with escitalopram response in depression: a Canadian Biomarker Integration Network in Depression (CAN-BIND-1) Report.

Authors:  Katharine Dunlop; Sakina J Rizvi; Sidney H Kennedy; Stefanie Hassel; Stephen C Strother; Jacqueline K Harris; Mojdeh Zamyadi; Stephen R Arnott; Andrew D Davis; Farrokh Mansouri; Laura Schulze; Amanda K Ceniti; Raymond W Lam; Roumen Milev; Susan Rotzinger; Jane A Foster; Benicio N Frey; Sagar V Parikh; Claudio N Soares; Rudolf Uher; Gustavo Turecki; Glenda M MacQueen; Jonathan Downar
Journal:  Neuropsychopharmacology       Date:  2020-07       Impact factor: 7.853

Review 4.  Presentation and Neurobiology of Anhedonia in Mood Disorders: Commonalities and Distinctions.

Authors:  Sakina J Rizvi; Clare Lambert; Sidney Kennedy
Journal:  Curr Psychiatry Rep       Date:  2018-03-08       Impact factor: 5.285

Review 5.  Assessing anhedonia in depression: Potentials and pitfalls.

Authors:  Sakina J Rizvi; Diego A Pizzagalli; Beth A Sproule; Sidney H Kennedy
Journal:  Neurosci Biobehav Rev       Date:  2016-03-06       Impact factor: 8.989

Review 6.  Translational Assessments of Reward and Anhedonia: A Tribute to Athina Markou.

Authors:  Andre Der-Avakian; Diego A Pizzagalli
Journal:  Biol Psychiatry       Date:  2018-02-24       Impact factor: 13.382

7.  Anhedonia as a key clinical feature in the maintenance and treatment of opioid use disorder.

Authors:  Brian D Kiluk; Sarah W Yip; Elise E DeVito; Kathleen M Carroll; Mehmet Sofuoglu
Journal:  Clin Psychol Sci       Date:  2019-09-23

8.  Effects of inescapable stress on responses to social incentive stimuli and modulation by escitalopram.

Authors:  Stephen Daniels; Danielle Lemaire; Thomas Lapointe; Cheryl Limebeer; Linda Parker; Francesco Leri
Journal:  Psychopharmacology (Berl)       Date:  2021-07-30       Impact factor: 4.530

9.  Neurophysiological markers of response to theta burst stimulation in youth depression.

Authors:  Prabhjot Dhami; Sravya Atluri; Jonathan Lee; Yuliya Knyahnytska; Paul E Croarkin; Daniel M Blumberger; Zafiris J Daskalakis; Faranak Farzan
Journal:  Depress Anxiety       Date:  2020-10-01       Impact factor: 6.505

10.  Prefrontal Cortical Reactivity and Connectivity Markers Distinguish Youth Depression from Healthy Youth.

Authors:  Prabhjot Dhami; Sravya Atluri; Jonathan C Lee; Yuliya Knyahnytska; Paul E Croarkin; Daniel M Blumberger; Zafiris J Daskalakis; Faranak Farzan
Journal:  Cereb Cortex       Date:  2020-06-01       Impact factor: 5.357

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.